EcomVA Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • EcomVA's estimated annual revenue is currently $1.1M per year.(i)
  • EcomVA's estimated revenue per employee is $84,000

Employee Data

  • EcomVA has 13 Employees.(i)
  • EcomVA grew their employee count by -41% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$169.8M18275%$29M$3B
Add Company

What Is EcomVA?

EcomVA Virtual assistant services help businesses in several ways as they have skills, time, and resources. Remote work is becoming highly popular and giving new opportunities to businesses. They allow scaling businesses rapidly and making more money.

keywords:Ecommerce Virtual assistant

N/A

Total Funding

13

Number of Employees

$1.1M

Revenue (est)

-41%

Employee Growth %

N/A

Valuation

N/A

Accelerator

EcomVA News

2021-09-08 - Tergus Pharma Makes Key Executive Hires

DURHAM, N.C. (PRWEB) September 08, 2021 Tergus Pharma, the leading topical Contract Development and Manufacturing Organization (CDMO) with proven topical expertise, announced today the hiring of James Valenzuela as Chief Operations Officer and Drew Bradley as Vice President of Sales and Marketi ...

2021-05-24 - Prominent CDMO Tergus Pharma Officially Opens New Headquarters

Ribbon Cutting at Tergus Pharma May 13, 2021 I’m delighted to be here today to celebrate not only Tergus Pharma, but also to celebrate North Carolina’s ecosystem of innovation, entrepreneurship, biotechnology, and life sciences. (Gov. Roy Cooper) DURHAM, N.C. (PRWEB) May 24, 2021 Tergus Pharma ...

2021-05-11 - Prominent CDMO Tergus Pharma Officially Opens New Headquarters

Tergus Pharma Manufacturing Site DURHAM, N.C. (PRWEB) May 11, 2021 Tergus Pharma, the leading topical Contract Development and Manufacturing Organization (CDMO) with proven topical expertise, will officially open its new, 100,000 sq. ft. headquarters and commercial manufacturing facility with ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.3M13-24%N/A
#2
$1.1M13N/AN/A
#3
$1.9M130%N/A
#4
$0.8M1318%N/A
#5
$1.1M13-41%N/A